CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −934 | $484.92 | $453K | 37,456 |
| 2026-02-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −675 | $485.52 | $328K | 36,781 |
| 2026-02-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 50,100 | ||
| 2026-02-03 | MALCOLM JAN Director | Sale 10b5-1 | −50 | $474.23 | $24K | 270 |
| 2026-02-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +14,625 | $117.76 | $1.7M | 14,625 |
| 2026-02-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −14,625 | $470.95 | $6.9M | 0 |
| 2026-02-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2026-02-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $470.95 | $3.7M | 0 |
| 2026-02-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −14,625 | 38,625 | ||
| 2026-02-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −7,875 | 20,815 | ||
| 2026-01-26 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +14,625 | $117.76 | $1.7M | 14,625 |
| 2026-01-26 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −14,625 | $471.91 | $6.9M | 0 |
| 2026-01-26 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2026-01-26 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $471.91 | $3.7M | 0 |
| 2026-01-26 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −14,625 | 53,250 | ||
| 2026-01-26 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −7,875 | 28,690 | ||
| 2026-01-21 | Tracey Kevin Director | Grant or award · Restricted Stock Unit | +1,220 | 1,220 | ||
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −63 | $456.87 | $29K | 7,812 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −372 | $457.92 | $170K | 7,440 |
Page 159 of 171 · 3,408 trades